Recall D-0190-2025

US Class II Ongoing · initiated 2024-12-30

Recalling firm

Rising Pharma Holding, Inc., NJ

Product

Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

Reason for recall

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

← All recalls